Summary:
A Phase IIb, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of study medication in subjects with COPD
Qualified Participants Must:
• Be age 40 to 80
• current or former smoker
• have COPD diagnosis
• have COPD symptoms
• capable of withholding from short-acting bronchodilators for 4 hours prior to spirometry testing
Qualified Participants May Receive:
Compensation for time/travel and visit with on-site Physician